Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024523 (
malabsorption
)
7,319
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heat-stable enterotoxin (STa), elaborated by enterotoxigenic Echerichia coli, is a worldwide cause of secretory diarrhea in infants and travelers. Both STa and
guanylin
, a peptide structurally similar to STa, increase intracellular cGMP levels after binding to the same intestinal receptor, guanylate cyclase C (GC-C). Distinct from its role as an intestinal secretagogue,
guanylin
may also have a role in intestinal proliferation, as
guanylin
expression is lost in intestinal adenomas. To determine the function of
guanylin
in intestinal epithelia,
guanylin
null mice were generated using a Cre/loxP-based targeting vector.
Guanylin
null mice grew normally, were fertile and showed no signs of
malabsorption
. However, the levels of cGMP in colonic mucosa of
guanylin
null mice were significantly reduced. The colonic epithelial cell migration rate was increased and increased numbers of colonocytes expressing proliferating cell nuclear antigen (PCNA) were present in crypts of
guanylin
null mice as well. The apoptotic index was similar in
guanylin
null mice and littermate controls. We conclude from these studies that loss of
guanylin
results in increased proliferation of colonic epithelia. We speculate that the increase in colonocyte number is related to decreased levels of cGMP and that this increase in proliferation plays a role in susceptibility to intestinal adenoma formation and/or progression.
...
PMID:Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. 1246 32